Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Imunon Inc (IMNN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Imunon's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.3100 -0.0350    -2.60%
30/04 - Closed. Currency in USD ( Disclaimer )
After Hours
1.3100
0.0000
0.0000%
0:26:38 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 27,370
  • Bid/Ask: 1.2800 / 1.3700
  • Day's Range: 1.2800 - 1.3700
Imunon 1.3100 -0.0350 -2.60%

Imunon Inc Company Profile

 
Get an in-depth profile of Imunon Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

33

Equity Type

ORD

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and next-generation vaccines to treat cancer and infectious diseases. The Company’s lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. It also develops ThermoDox, a direct chemotherapy. In addition, the company is developing IMNN-101, a COVID-19 booster vaccine which is in preclinical trials; IMNN-102 for the of the Lassa virus which is in preclinical trials; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. Further, it develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon’s DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase and will focus on the development of personalized cancer vaccines, or neoepitope cancer vaccines. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is headquartered in Lawrenceville, New Jersey.

Contact Information

Address 997 Lenox Drive Suite 100
Lawrenceville, 08648
United States
Phone 609 896 9100
Fax 609 896 2200

Top Executives

Name Age Since Title
Michael H. Tardugno 71 2007 Executive Chairman
Donald P. Braun 74 2015 Independent Director
Wafik El-Deiry - - Member of Advisory Board
Frederick J. Fritz 73 2011 Independent Director
Mark W. Dewhirst - - Member of Advisory Board
Michael E. Weinblatt - - Member of Advisory Board
David Cheresh - - Member of Advisory Board
Jerry Glickson - - Member of Advisory Board
Britt A. Glaunsinger - 2021 Member of the Advisory Board
Luke D. Handke - 2021 Member of Vaccine Advisory Board
Patrick Ott - 2023 Member of Scientific Advisory Board
Peter Corry - - Member of Advisory Board
Stacy R. Lindborg 54 2021 Independent Director
Xinzhen Yang - 2021 Member of the Advisory Board
Christine A. Pellizzari 56 2021 Independent Director
Dan H. Barouch - 2021 Member of Vaccine Advisory Board
Sachet A. Shukla - 2023 Member of Scientific Advisory Board
James E. Dentzer 57 2022 Independent Director
John W. Shiver - - Member of Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IMNN Comments

Write your thoughts about Imunon Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email